A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community

Valentina Cannone, Guido Boerrigter, Alessandro Cataliotti, Lisa C. Costello-Boerrigter, Timothy M. Olson, Paul M. McKie, Denise M. Heublein, Brian D. Lahr, Kent R. Bailey, Maurizio Averna, Margaret M. Redfield, Richard J. Rodeheffer, John C. Burnett

Research output: Contribution to journalArticlepeer-review

70 Scopus citations


Objectives: We sought to define the cardiometabolic phenotype associated with rs5068, a genetic variant of the atrial natriuretic peptide (ANP) gene. Background: The ANP and B-type natriuretic peptide play an important role in cardiorenal homeostasis but also exert metabolic actions. Methods: We genotyped 1,608 randomly selected residents from Olmsted County, Minnesota. Subjects were well-characterized. Results: Genotype frequencies were: AA 89.9%, AG 9.7%, and GG 0.4%; all subsequent analyses were AA versus AG+GG. The G allele was associated with increased plasma levels of N-terminal pro-atrial natriuretic peptide (p = 0.002), after adjustment for age and sex. The minor allele was also associated with lower body mass index (BMI) (p = 0.006), prevalence of obesity (p = 0.002), waist circumference (p = 0.021), lower levels of C-reactive protein (p = 0.027), and higher values of high-density lipoprotein cholesterol (p = 0.019). The AG+GG group had a lower systolic blood pressure (p = 0.011) and lower prevalence of myocardial infarction (p = 0.042). The minor allele was associated with a lower prevalence of metabolic syndrome (p = 0.025). The associations between the G allele and high-density lipoprotein cholesterol, C-reactive protein values, myocardial infarction, and metabolic syndrome were not significant, after adjusting for BMI; the associations with systolic blood pressure, BMI, obesity, and waist circumference remained significant even after adjusting for N-terminal pro-atrial natriuretic peptide. Conclusions: In a random sample of the general U.S. population, the minor allele of rs5068 is associated with a favorable cardiometabolic profile. These findings suggest that rs5068 or genetic loci in linkage disequilibrium might affect susceptibility for cardiometabolic diseases and support the possible protective role of natriuretic peptides by their favorable effects on metabolic function. Replication studies are needed to confirm our findings.

Original languageEnglish (US)
Pages (from-to)629-636
Number of pages8
JournalJournal of the American College of Cardiology
Issue number6
StatePublished - Aug 2 2011


  • atrial natriuretic peptide
  • cardiometabolic disease
  • lipid metabolism
  • metabolic syndrome
  • natriuretic peptides

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community'. Together they form a unique fingerprint.

Cite this